ABCL
AbCellera Biologics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
—
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
AbCellera Biologics Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
—
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
AbCellera Biologics Inc.
12.26
−0.82 · −6.27%
post 12.22 −0.32%
No N-PORT holders.
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Baker Bros. AdvisorsBaker Bros. | $259.1M | 27.01% | +9.04% | |
| 2 | Capital World InvestorsCapital World Investors | $106.7M | 11.12% | +1.70% | |
| 3 | Two Sigma InvestmentsTwo Sigma | $81.9M | 8.54% | −1.18% | |
| 4 | TD Waterhouse CanadaTD Waterhouse Canada | $72.6M | 7.57% | +0.04% | |
| 5 | Bank of AmericaBank of America | $48.2M | 5.02% | +104.72% | |
| 6 | UBS Asset Management AmericasUBS Asset Management Americas | $33.9M | 3.53% | −43.01% | |
| 7 | Arrowpoint Asset ManagementArrowpoint | $32.2M | 3.36% | 0.00% | |
| 8 | BlackRockBlackRockindex-like | $29.9M | 3.11% | −5.81% | |
| 9 | Susquehanna International GroupSusquehanna International | $24.5M | 2.55% | +42.21% | |
| 10 | Driehaus Capital ManagementDriehaus | $22.5M | 2.34% | −28.82% | |
| 11 | Citadel AdvisorsCitadel | $21.6M | 2.25% | +46.40% | |
| 12 | UBS GroupUBS | $16.3M | 1.69% | −50.81% | |
| 13 | Tudor Investment Corp ET ALTudor Investment Corp ET AL | $16.2M | 1.69% | −9.25% | |
| 14 | Marshall WaceMarshall Wace | $14.9M | 1.56% | +428.85% | |
| 15 | Morgan StanleyMorgan Stanley | $13.1M | 1.37% | −24.98% | |
| 16 | T. Rowe Price AssociatesT. Rowe Price | $12.5M | 1.30% | new | |
| 17 | National Bank of CanadaNational Bank of Canada | $9.7M | 1.01% | +88415.00% | |
| 18 | Daiwa Securities GroupDaiwa Securities | $8.8M | 0.92% | new | |
| 19 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $8.2M | 0.85% | new | |
| 20 | Renaissance TechnologiesRenaissance Technologies | $7.8M | 0.81% | −34.40% | |
| 21 | Counterpoint Mutual FundsCounterpoint Mutual Funds | $7.6M | 0.79% | new | |
| 22 | OZ ManagementOZ Management | $7.1M | 0.74% | new | |
| 23 | Bank of MontrealBank of Montreal | $7.0M | 0.72% | +387.59% | |
| 24 | State StreetState Streetindex-like | $5.7M | 0.60% | +0.16% | |
| 25 | HRT FinancialHRT Financial | $5.5M | 0.58% | −42.88% |
150 managers report $959.6M of AbCellera Biologics on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; Baker Bros. is largest at 27.01%.
Linked news
Expected move
Inputsstraddle ±17.0%
spot 12.27exp Nov 20ATM strike 12ATM straddle 2.45IV 105%